Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2020

13.12.2018 | Editorial

Transient ischemic dilation in hypertrophic cardiomyopathy: A complex sign in a complex disease

verfasst von: Roberto Sciagrà, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

Left ventricular (LV) cavity dilation, better known as transient ischemic dilation (TID), is an indirect marker of ischemia in myocardial perfusion imaging, already described in Thallium-201 scans several years ago. The proposed mechanisms for this abnormality are related to the presence of severe stress-induced ischemia.1 A first possible explanation is the occurrence of more pronounced ischemia in the subendocardial layer of the myocardium, with consequent apparent enlargement of the ventricular cavity.2 Alternatively, the systolic dysfunction due to ischemia could persist until the moment of image acquisition, according to the model of myocardial stunning, and the ensuing reduction in wall motion and thickening cause an apparent decrease in myocardial uptake due to the partial volume effect, which is mainly recognizable as an enlarged ventricular cavity.3 Experimental evidences have confirmed that a true increase in LV end diastolic dimensions is relatively rare, whilst a larger end systolic volume, with the additional consequence of a decrease in LV ejection fraction (EF) is a commonplace observation.3 Independently of the true mechanism, and most probably because they are often both involved, TID has been found to be a very important and reliable sign of severe ischemia.1,4 This has been confirmed within all different modalities of myocardial perfusion imaging, including all used tracers, stressors, and protocols, although various definitions and cutoff values have been proposed. Its sensitivity for the detection of multivessel coronary disease ranged from 38% to 80%, and its specificity was consistently higher than 90%.1,4 However, in the general population of patients studied for suspect or known epicardial coronary artery disease its incidence is quite low, probably less than 10%.5
Literatur
1.
Zurück zum Zitat McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.CrossRef McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.CrossRef
2.
Zurück zum Zitat Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.CrossRef Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.CrossRef
3.
Zurück zum Zitat Van Tosh A, Hecht S, Berger M, Roberti R, Luna E, Horowitz SF. Exercise echocardiographic correlates of transient dilatation of the left ventricular cavity on exercise thallium-201 SPECT imaging. Chest 1994;106:1725-9.CrossRef Van Tosh A, Hecht S, Berger M, Roberti R, Luna E, Horowitz SF. Exercise echocardiographic correlates of transient dilatation of the left ventricular cavity on exercise thallium-201 SPECT imaging. Chest 1994;106:1725-9.CrossRef
4.
Zurück zum Zitat Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.CrossRef Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.CrossRef
5.
Zurück zum Zitat Hansen CL, Sangrigoli R, Nkadi E, Kramer M. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging. J Am Coll Cardiol 1999;33:1323-7.CrossRef Hansen CL, Sangrigoli R, Nkadi E, Kramer M. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging. J Am Coll Cardiol 1999;33:1323-7.CrossRef
6.
Zurück zum Zitat Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75.CrossRef Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75.CrossRef
7.
Zurück zum Zitat O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography. Circulation 1987;76:1214-23.CrossRef O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography. Circulation 1987;76:1214-23.CrossRef
8.
Zurück zum Zitat Sugihara H, Shiga K, Umamoto I, Harada Y, Katahira T, Nakagawa T, Nakamura T, Matsubara K, Terashima S, Azuma A, Katsume H, Nakagawa M. Assessment of transient dilation of the LV cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy. Kaku Igaku 1990;27:1281-9 [in Japanese].PubMed Sugihara H, Shiga K, Umamoto I, Harada Y, Katahira T, Nakagawa T, Nakamura T, Matsubara K, Terashima S, Azuma A, Katsume H, Nakagawa M. Assessment of transient dilation of the LV cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy. Kaku Igaku 1990;27:1281-9 [in Japanese].PubMed
9.
Zurück zum Zitat Cannon RO 3rd, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-7.CrossRef Cannon RO 3rd, Dilsizian V, O’Gara PT, Udelson JE, Schenke WH, Quyyumi A, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-7.CrossRef
10.
Zurück zum Zitat Kawasaki T, Sugihara H. Subendocardial ischemia in hypertrophic cardiomyopathy. J Cardiol 2014;63:89-94.CrossRef Kawasaki T, Sugihara H. Subendocardial ischemia in hypertrophic cardiomyopathy. J Cardiol 2014;63:89-94.CrossRef
11.
Zurück zum Zitat Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRef Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRef
12.
Zurück zum Zitat Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, et al. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol 2016;23:1304-14.CrossRef Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, et al. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol 2016;23:1304-14.CrossRef
13.
Zurück zum Zitat Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, et al. Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by 13N-Ammonia perfusion PET in patients with hypertrophic cardiomyopathy. Am J Cardiol 2016;118:1908-15.CrossRef Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, et al. Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by 13N-Ammonia perfusion PET in patients with hypertrophic cardiomyopathy. Am J Cardiol 2016;118:1908-15.CrossRef
14.
Zurück zum Zitat Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;294:H986-93.CrossRef Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;294:H986-93.CrossRef
15.
Zurück zum Zitat Sciagrà R, Passeri A, Cipollini F, Castagnoli H, Olivotto I, Burger C, et al. Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging 2015;42:1581-8.CrossRef Sciagrà R, Passeri A, Cipollini F, Castagnoli H, Olivotto I, Burger C, et al. Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy. Eur J Nucl Med Mol Imaging 2015;42:1581-8.CrossRef
16.
Zurück zum Zitat Sciagrà R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, et al. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: A 13NH3 gated PET study. Eur J Nucl Med Mol Imaging 2017;44:866-75.CrossRef Sciagrà R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, et al. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: A 13NH3 gated PET study. Eur J Nucl Med Mol Imaging 2017;44:866-75.CrossRef
18.
Zurück zum Zitat Isobe S, Izawa H, Takeichi Y, Nonokawa M, Nanasato M, Ando A, et al. Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2003;44:1717-24.PubMed Isobe S, Izawa H, Takeichi Y, Nonokawa M, Nanasato M, Ando A, et al. Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2003;44:1717-24.PubMed
19.
Zurück zum Zitat Sambuceti G, Morbelli S, Bellini A, Marini C. Radionuclide imaging of subendocardial ischaemia: An insight into coronary pathophysiology or a technical artefact? Eur J Nucl Med Mol Imaging 2017;44:861-5.CrossRef Sambuceti G, Morbelli S, Bellini A, Marini C. Radionuclide imaging of subendocardial ischaemia: An insight into coronary pathophysiology or a technical artefact? Eur J Nucl Med Mol Imaging 2017;44:861-5.CrossRef
20.
Zurück zum Zitat Reant P, Dufour M, Peyrou J, Reynaud A, Rooryck C, Dijos M, et al. Upright treadmill vs semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: A pilot study. Eur Heart J Cardiovasc Imaging 2018;19:31-8.CrossRef Reant P, Dufour M, Peyrou J, Reynaud A, Rooryck C, Dijos M, et al. Upright treadmill vs semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: A pilot study. Eur Heart J Cardiovasc Imaging 2018;19:31-8.CrossRef
Metadaten
Titel
Transient ischemic dilation in hypertrophic cardiomyopathy: A complex sign in a complex disease
verfasst von
Roberto Sciagrà, MD
Publikationsdatum
13.12.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2020
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-01567-x

Weitere Artikel der Ausgabe 6/2020

Journal of Nuclear Cardiology 6/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.